Shoppers Drug Mart Corporation receives decision from the Supreme Court of Canada on the prohibition on private label generic drug products in the Province of Ontario

TORONTO, Nov. 22, 2013 /CNW/ - Shoppers Drug Mart Corporation (TSX: SC) today announced that the Supreme Court of Canada has upheld the December 23, 2011 decision of the Court of Appeal of Ontario that restored the prohibition on private label generic drug products in the Province of Ontario, which was subsequent to a decision of the Ontario Divisional Court dated February 3, 2011 that declared the regulatory restrictions in respect of private label generic drug products to be invalid.

While the Company respects the decision of the Supreme Court of Canada, it is disappointed with the outcome.

About Shoppers Drug Mart Corporation

Shoppers Drug Mart Corporation is one of the most recognized and trusted names in Canadian retailing.  The Company is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart (Pharmaprix in Québec).  With more than 1,246 Shoppers Drug Mart and Pharmaprix stores operating in prime locations in each province and two territories, the Company is one of the most convenient retailers in Canada.  The Company also licenses or owns 55 medical clinic pharmacies operating under the name Shoppers Simply Pharmacy (Pharmaprix Simplement Santé in Québec) and six luxury beauty destinations operating as Murale.  As well, the Company owns and operates 62 Shoppers Home Health Care stores, making it the largest Canadian retailer of home health care products and services.  In addition to its retail store network, the Company owns Shoppers Drug Mart Specialty Health Network Inc., a provider of specialty drug distribution, pharmacy and comprehensive patient support services; and MediSystem Technologies Inc., a provider of pharmaceutical products and services to long-term care facilities.

For more information, visit www.shoppersdrugmart.ca.

SOURCE: Shoppers Drug Mart Corporation

Media Contact:
Tammy Smitham
Vice President, Communications & Corporate Affairs
[phone]

Investor Relations:
[phone], ext. 5678
[email protected]